Earlier today, Moderna, Inc. (Nasdaq: MRNA) announced it has completed the rolling submission process for its Biologics License Application (BLA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Momentum Movers Trader Talk

Moderna (MRNA) Completes Submission of BLA to U.S. Food and Drug Administration for its COVID-19 VaccineAugust 25, 2021 9:44 AM COVID vaccine protection wanes within six months - UK researchersAugust 25, 2021 9:25 AM U.S. data show rising 'breakthrough' infections among fully vaccinatedAugust 24, 2021 2:27 PM U.S. could control COVID by spring 2022 if more people get shots -FauciAugust 24, 2021 8:01 AM Popular stocks with increasing volume: MRNA PFE GM UBER PLTRAugust 23, 2021 4:02 PM Pentagon Prepared To Issue Updated Guidance To Require All Personnel To Be Vaccinated After Pfizer Vaccine FDA ApprovalAugust 23, 2021 10:56 AM The FDA has granted full approval of Pfizer (PFE)/BioNTech SE (BNTX) COVID-19 vaccine - WaPoAugust 23, 2021 9:33 AM